Pill Identifier App

607 (Chlordiazepoxide and Clidinium 5 mg / 2.5 mg)

Pill imprint 607 has been identified as Chlordiazepoxide hydrochloride and clidinium bromide 5 mg / 2.5 mg.

Chlordiazepoxide/clidinium is used in the treatment of irritable bowel syndrome; enterocolitis; peptic ulcer and belongs to the drug class anticholinergics/antispasmodics. There is positive evidence of human fetal risk during pregnancy. Chlordiazepoxide/clidinium 5 mg / 2.5 mg has a low potential for abuse relative to the drugs in schedule 3. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.

See also related documents.

Imprint Search

Images for 607

Chlordiazepoxide hydrochloride and clidinium bromide 5 mg / 2.5 mg 607
Chlordiazepoxide hydrochloride and clidinium bromide
Imprint:
607
Strength:
5 mg / 2.5 mg
Color:
Green
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Anticholinergics/antispasmodics
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
4 - Some potential for abuse
Manufacturer:
Macoven Pharmaceuticals

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web3)